Finally, according to the statistics of TCGA cohort, among all cancers, the mutation frequency of G3BP1 in EC is the highest, coming to 5.27% (27/512), including missense mutation, synonymous mutation, and nonsense mutation (Fig. 1L). This evidence concerns the gene G3BP1 and cancer.